|
WO2008001849A1
|
|
Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent
|
|
JP2007210963A
|
|
Pyrimidine nucleoside derivative and salt thereof
|
|
JP2005336157A
|
|
Method for producing optically active thalidomide and derivative thereof
|
|
JP2006122010A
|
|
Agent for preventing and treating leishmaniasis and chargas' disease by inhibition of new quinol oxidase
|
|
CN1822841A
|
|
Anti-coronavirus drug
|
|
WO2005037759A1
|
|
Novel phenol derivative and antitrypanosoma preventive/therapeutic agent containing the same as active ingredient
|
|
JP2005112755A
|
|
Cryptosporidium disease-preventing/treating agent containing phenolic derivative as active ingredient
|
|
WO2004069261A1
|
|
Process for producing antiherpesvirus preparation for external use
|
|
JP2003043023A
|
|
Method for quantitatively determining orcenyl aldehyde compound in blood
|
|
JP2005053780A
|
|
New ligand of intranuclear receptor superfamily and method for producing the same and use thereof
|
|
EP1176134A1
|
|
Ligands of nuclear receptors ppar's
|
